Lichen-Derived Diffractaic Acid Inhibited Dengue Virus Replication in a Cell-Based System.
Naphat LoeanuritTruong Lam TuongVan-Kieu NguyenVipanee VibulakhaophanKowit HengphasatpornYasuteru ShigetaSi Xian HoJustin Jang Hann ChuThanyada RungrotmongkolWarinthorn ChavasiriSiwaporn BoonyasuppayakornPublished in: Molecules (Basel, Switzerland) (2023)
Dengue is a mosquito-borne flavivirus that causes 21,000 deaths annually. Depsides and depsidones of lichens have previously been reported to be antimicrobials. In this study, our objective was to identify lichen-derived depsides and depsidones as dengue virus inhibitors. The 18 depsides and depsidones of Usnea baileyi , Usnea aciculifera , Parmotrema dilatatum , and Parmotrema tsavoense were tested against dengue virus serotype 2. Two depsides and one depsidone inhibited dengue virus serotype 2 without any apparent cytotoxicity. Diffractaic acid, barbatic acid, and Parmosidone C were three active compounds further characterized for their efficacies (EC 50 ), cytotoxicities (CC 50 ), and selectivity index (SI; CC 50 /EC 50 ). Their EC 50 (SI) values were 2.43 ± 0.19 (20.59), 0.91 ± 0.15 (13.33), and 17.42 ± 3.21 (8.95) μM, respectively. Diffractaic acid showed the highest selectivity index, and similar efficacies were also found in dengue serotypes 1-4, Zika, and chikungunya viruses. Cell-based studies revealed that the target was mainly in the late stage with replication and the formation of infectious particles. This report highlights that a lichen-derived diffractaic acid could become a mosquito-borne antiviral lead as its selectivity indices ranged from 8.07 to 20.59 with a proposed target at viral replication.